Parabilis Medicines, Inc. Common Stock (PBLS)

Parabilis Medicines, Inc. Common Stock (PBLS) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $3.1B; returns 1 day -9.2%, 1 week +7.4%.

Parabilis Medicines, Inc. (formerly FogPharma) is a clinical-stage biopharmaceutical company focused on commercializing a new therapeutic modality called 'Helicons'—stabilized, cell-penetrant alpha-helical peptides designed to engage 'undruggable' intracellular protein targets.

Groups PBLS belongs to

• Biotechnology
• Biopharmaceutical
• Recent IPOs
• Clinical Stage
• Clinical Stage Biotech
• Oncology
• Cancer Therapeutics
• R&D
• Life Sciences
• Antibody-Drug Conjugates
• Drug Discovery
• Strategic Partnerships
• Artificial Intelligence

PBLS financial model: income statement, cash flow and balance sheet